Itgam, as one of the potential core therapeutic targets in patients with ischemic stroke, may play a role by regulating the secretion of key inflammatory factors, IL-1β, IL-6 and TNF-α, and influencing neuronal apoptosis (48). This evidence concerns the gene IL1B and ischemic stroke.